Skip to main content
SpringerLink
Log in
Book cover

Current Cardiovascular Drugs pp 194–214Cite as

Inotropic and Vasopressor Agents

  • Chapter

  • 139 Accesses

Abstract

The major aim of inotropic therapy is to improve ventricular contractility of the depressed heart so as to increase cardiac output as needed and reduce elevated ventricular filling pressures. They may be employed intravenously for acute ventricular failure (eg, phosphodiesterase (PDE) III inhibitors or catecholamines) or chronically as oral agents (eg, digitalis glycosides).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Selected Bibliography

  • Alousi AA, Johnson DC: Pharmacology of the bipyridines: amrinone and mirinone. Circulation 1986; 70 (Suppl II): 11–110–23.

    Google Scholar 

  • Anversa P. Sonnenblick EH: Ischemic cardiomyopathy: pathophysiological mechanisms. Prog Cardiovasc Dis 1990; 33: 49–70.

    Article  CAS  Google Scholar 

  • Braunwald E, Ross J Jr., Sonnenblick EH: Mechanisms of Contraction of the Normal and Failing Heart, 2nd ed. Boston: Little. Brown & Co.. 1976.

    Google Scholar 

  • Captopril-Digoxin Multicenter Research Group: Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA 1988; 259: 539–44.

    Google Scholar 

  • Cavusoglu E, Frishman WH, Klapholz M: Vesnarinone: A new inotropic agent for treating congestive heart failure. J Cardiac Fail 1995; 1: 249–57.

    Article  CAS  Google Scholar 

  • Cheng W, Li B. Kajstura J, et al.: Stretch-induced programmed myocyte cell death. J Clin Invest 1995; 96: 2247–59.

    Google Scholar 

  • Cohn 1N, Goldstein SO, Greenberg BH. et al.: A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. N Eng! J Med 1998, 339:1810–1816.

    Google Scholar 

  • Dei Cas L. Metrar M. Visioli O: Clinical pharmacology of in- olators. J Cardiovasc Pharmacy! 1989; 14 (8): S60–71.

    Google Scholar 

  • Garofalo F, Lalanne GM. Nanni G: Midodrine for female incontinence: a preliminary report. Clin Ther 1986; 9: 44–46.

    Google Scholar 

  • Goldberg LI: The role of dopamine receptors in the treatment of congestive heart failure. J Cardiavasc Pharmacy! 1989; 14(5): SI9–27.

    Google Scholar 

  • Goldberg LI, Rajfer SI: Dopamine receptors: Applications in clinical cardiology. Circulation 1985; 72: 245–48.

    Article  PubMed  CAS  Google Scholar 

  • Grose R, Strain J, Greenberg M, LeJemtel TH: Systemic and coronary effects of intravenous mirinone and dobutamine in congestive heart failure. JAm Call Cardiol 1986; 7: 1107–13.

    Article  CAS  Google Scholar 

  • Grossman W: Diastolic dysfunction in congestive heart failure. New Engl J Med 1991; 325: 1557–64.

    Article  PubMed  CAS  Google Scholar 

  • Haikala H, Linden I: Mechanisms of action of calcium-sensitizing drugs. J Cardiavasc Pharm 1995; 26 (Suppl. 1): S10–19.

    CAS  Google Scholar 

  • Insel PA: Adrenergic receptors–evolving concepts and clinical implications. N Engl J Med 1996: 334: 580–85.

    Article  PubMed  CAS  Google Scholar 

  • Jakovic J. Gilden 1L, Hiner BC, et al.: Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med 1993; 95: 38–48.

    Google Scholar 

  • Kelley RA, Smith TW: Recognition and treatment of digitalis toxicity. Am J Cordial 1992: 69: 108G - 119G.

    Article  Google Scholar 

  • LeJemtel TH, Sonnenblick EH, Frishman WH: Diagnosis and management of heart failure. In Alexander RW, Schlant RC, Fuster V. (eds): Hurst’s the Handbook, 9th ed. New York: McGraw Hill, 1998: 745–81.

    Google Scholar 

  • Lewis RP: Clinical use of serum digoxin concentrations. Am J Cordial 1992; 69: 97G - 107G.

    Article  CAS  Google Scholar 

  • Lilleberg J, Sundberg S. Nieminen MS: Dose-range study of a new calcium sensitizer, levosimendan, in patients with left ventricular dysfunction. J Cardiovasc Pharmacy’ 1995; 26 (Suppl 1): S63–69.

    CAS  Google Scholar 

  • Low PA, Gilden JL, Freeman R. et al.: Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension: a randomized, double-blind multicenter study. Midodrine Study Group. JAMA 1997; 227: 1046–1051.

    Google Scholar 

  • McTavish D. Goa KL: Midodrine: a review of its pharmac logical properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders. Drugs 1989; 38: 757–777.

    Article  PubMed  CAS  Google Scholar 

  • Majerus IC. Dasta JF, Bauman JL, et a Dobutatnine: years later. Pharmacotherapy 1989; 9: 245–59. -

    Google Scholar 

  • Newton GE. Tong 1H, Schofield AM, et al Digoxin reduces cardiac sympathetic activity in severe congestive heart failure. JAm Coll Cordial 1996; 28: 155–61.

    Google Scholar 

  • Packer M: Do positive inotropic agents adversely affect the survival of patients with chronic congestive heart failure? 11. Protagonist’s viewpoint. JAm Coll Cardiol 1988; 12: 562–66.

    Article  CAS  Google Scholar 

  • Packer M, Carver JR, Rodeheffer RJ, et al: Effect of ora rinone on mortality in severe chronic heart failure. N Eng! Med 1991; 325: 1468–75.

    Article  CAS  Google Scholar 

  • Packer M, Gheorghiade M, Young JB, et al: Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N Eng! Med 1993; 329: 1–7.

    Article  CAS  Google Scholar 

  • Rector TW, Cohn IN: Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J 199 124: 1017–25.

    Google Scholar 

  • Ruffolo RR Jr.: Review: The pharmacology of dobutamine. Am J Med Sci 1987; 294: 244–48.

    Article  PubMed  Google Scholar 

  • Scholz H: Inotropic drugs and their mechanisms of action. J Am Col! Cordial 1984; 4: 389–97.

    Article  CAS  Google Scholar 

  • Smith TW: Digitalis: mechanisms of action and clinical u: N Engl J Med 1988; 31: 358–65.

    Google Scholar 

  • Sonnenblick EH, Frishman WH, LeJemtel TH: Dobutamin A new synthetic cardioactive sympathetic amine. N Eng Med 1979; 300: 17–22.

    Article  CAS  Google Scholar 

  • Sonnenblick EH, LeJemtel TH: Heart Failure: Its progression and its therapy. Hasp Pract 1993; 28: 121–30.

    CAS  Google Scholar 

  • Sonnenblick EH, LeJemtel TH, Frishman WH: Digitalis preparations and other inotropic agents. In Frishman WH, Sonnenblick EH (eds): Cardiovascular Pharmacotherapeutics. New York: McGraw Hill, 1997: 237–50.

    Google Scholar 

  • Tauke J, Goldstein S. Gheorghiade M: Digoxin for chronic heart failure: A review of the randomized controlled trials with special attention to the PROVED and RADIANCE Trials. Prog Cardiovase Dis 1994; 37: 49–58.

    Article  CAS  Google Scholar 

  • The Digitalis Investigation Group: The effect of digoxin on mortality and morbidity in patients with heart failure. N Eng! J Med 1997; 336: 525–33.

    Article  Google Scholar 

  • Tisdale JE. Patel R, Webb CR, et al: Electrophysiologic and proarrhythmic effects of intravenous inotropic agents. Prog Cardiovasc Dis 1995; 38: 167–80.

    Google Scholar 

  • Uretsky BF, Young JB. Shahidi FE, et al.: Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of the PROVED Trial. J Am Coll Cardiol 1995; 22: 955–60.

    Google Scholar 

  • Wright RA, Kaufmann HC, Perera R. et al.: A double-blind. dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology 1998; 51: 120–124.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Westchester Medical Center, New York Medical College, Valhalla, New York, USA

    William H. Frishman M.D. (Professor of Medicine and Pharmacology, Chairman of Medicine, Director of Medicine)

  2. Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA

    Angela Cheng-Lai Pharm.D. (Clinical Pharmacy Manager, Adult Medicine, Assistant Professor of Medicine) & Julie Chen Pharm.D., BCPS (Clinical Pharmacy Manager, Critical Care, Assistant Professor of Medicine)

Authors
  1. William H. Frishman M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Angela Cheng-Lai Pharm.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Julie Chen Pharm.D., BCPS
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Westchester Medical Center, New York Medical College, Valhalla, New York, USA

    William H. Frishman M.D. (Professor of Medicine and Pharmacology, Chairman of Medicine, Director of Medicine) (Professor of Medicine and Pharmacology, Chairman of Medicine, Director of Medicine)

  2. Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA

    Angela Cheng-Lai Pharm.D. (Clinical Pharmacy Manager, Adult Medicine, Assistant Professor of Medicine) & Julie Chen Pharm.D., BCPS (Clinical Pharmacy Manager, Critical Care, Assistant Professor of Medicine) (Clinical Pharmacy Manager, Adult Medicine, Assistant Professor of Medicine) &  (Clinical Pharmacy Manager, Critical Care, Assistant Professor of Medicine)

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media New York

About this chapter

Cite this chapter

Frishman, W.H., Cheng-Lai, A., Chen, J. (2000). Inotropic and Vasopressor Agents. In: Frishman, W.H., Cheng-Lai, A., Chen, J. (eds) Current Cardiovascular Drugs. Current Medicine Group, London. https://doi.org/10.1007/978-1-4615-6767-7_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-6767-7_11

  • Publisher Name: Current Medicine Group, London

  • Print ISBN: 978-1-57340-135-7

  • Online ISBN: 978-1-4615-6767-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation